retatrutide type 2 diabetes phase 2 trial A new weight-loss drug called is generating excitement after clinical participants lost an average of 30% of their body weight, results that rival or even exceed weight-loss surgery. Researchers also Weight loss with retatrutide as
Description
doi: 10.1007/s13300-020-00981-0 [DOI] [PMC free article] [PubMed] [Google Scholar] 21.Finan B, Ma T, Ottaway N, et al

Yes, and it can be one of the most effective combinations for women in midlife

References Blundell, J., Finlayson, G., Axelsen, M., et al
00967-0/asset/1cda1e69-507e-47d1-ad73-620bcd1cbb66/main.assets/gr2_lrg.jpg)
A recently published retrospective cohort study published in JAMA Network Open on July 5, 2024, noted a decrease in eleven obesity-associated cancers (OACs) in patients taking GLP-1 medications